XASXNUC
Market cap10mUSD
Jan 06, Last price
0.14AUD
Name
Nuchev Ltd
Chart & Performance
P/E
—
P/S
1.81
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
11.90%
Rev. gr., 5y
3.61%
Revenues
11m
+29.04%
Net income
-7m
L-16.92%
CFO
-4m
L+14.63%
Earnings
Feb 24, 2025
Profile
Nuchev Limited, a health and nutrition solutions company, produces, markets, and sells goat milk-based infant formula and nutritional products to consumers in Australia, China, and Vietnam. The company provides toddler nutrition, goat nutritional powder, and health and well-being products under the Oli6 brand. It offers its products through retailers and e-commerce platforms. Nuchev Limited was founded in 2013 and is headquartered in Melbourne, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||
Revenues | 11,345 29.04% | 8,792 -9.59% | 9,724 -10.79% | |||||
Cost of revenue | 22,618 | 17,248 | 18,990 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | (11,274) | (8,457) | (9,266) | |||||
NOPBT Margin | ||||||||
Operating Taxes | 287 | 705 | ||||||
Tax Rate | ||||||||
NOPAT | (11,274) | (8,744) | (9,971) | |||||
Net income | (7,316) -16.92% | (8,807) -25.45% | (11,813) -14.02% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 6,149 | 5,930 | ||||||
BB yield | -55.27% | -61.94% | ||||||
| Debt | ||||||||
Debt current | 86 | (1,383) | 154 | |||||
Long-term debt | 475 | 521 | 154 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | 165 | 81 | 83 | |||||
Net debt | (7,255) | (8,675) | (5,200) | |||||
| Cash flow | ||||||||
Cash from operating activities | (3,733) | (3,257) | (11,615) | |||||
CAPEX | (10) | (127) | (5) | |||||
Cash from investing activities | (2,186) | (127) | (914) | |||||
Cash from financing activities | 6,057 | 5,776 | (118) | |||||
FCF | (9,088) | (4,586) | (7,969) | |||||
| Balance | ||||||||
Cash | 7,610 | 7,494 | 5,127 | |||||
Long term investments | 205 | 319 | 381 | |||||
Excess cash | 7,248 | 7,373 | 5,022 | |||||
Stockholders' equity | 14,753 | 12,818 | 15,828 | |||||
Invested Capital | 7,993 | 5,810 | 11,043 | |||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 85,591 | 51,752 | 55,331 | |||||
Price | 0.13 -29.73% | 0.19 -2.63% | 0.19 -62.75% | |||||
Market cap | 11,127 16.22% | 9,574 -8.93% | 10,513 -62.13% | |||||
EV | 3,872 | 899 | 5,313 | |||||
EBITDA | (11,167) | (8,262) | (9,068) | |||||
EV/EBITDA | ||||||||
Interest | 26 | 73 | 6 | |||||
Interest/NOPBT | ||||||||